检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《中国免疫学杂志》2009年第8期745-747,751,共4页Chinese Journal of Immunology
基 金:吉林省科技厅资助课题(200505133)
摘 要:目的:观察环氧化酶-2(COX-2)在肺组织中的分布及其抑制剂对博莱霉素(BLM)诱导的大鼠肺纤维化模型的干预作用。方法:雄性SD大鼠72只随机分为3组,分别为对照组、模型组、塞来昔布组。采用免疫组织化学方法检测各组急性肺泡炎期肺部COX-2的表达和分布;HE和Masson染色方法观察肺泡炎和肺纤维化的程度。结果:(1)在肺纤维化早期,模型组和塞来昔布组均可见COX-2的表达,其主要分布在细支气管上皮细胞中,以模型组表达显著。(2)与对照组相比,模型组和塞来昔布组肺泡炎改变明显(P<0.01);塞来昔布干预组的肺泡炎症与模型组比较有所减轻(P<0.05)。(3)于实验第28、42天,模型组和塞来昔布组均可见肺纤维化改变,与对照组比较差异显著(P<0.01);但塞来昔布干预组与模型组比较无显著性差异(P>0.05)。结论:COX-2在肺纤维化早期高度表达,其主要分布在细支气管上皮细胞中;COX-2抑制剂可减轻早期肺泡炎症,对后期肺纤维化无明显抑制作用。Objective:To investigate the distribution and expression of the cyclooxygenase-2 (COX-2) in lung tissues and the effect of its inhibition in bteomycin (BLM)-induced pulmonary fibrosis in rats.Methods:72 male SD rats were randomly divided into three groups:the control group, model group and celecoxib group. Immunohistochemical method was used to detect the distribution of COX-2 in the stage of acute pulmonary alveolitis. HE and Masson staining methods were used to evaculate the degree of alveolitis and pulmonary fibrosis. Results: ( 1 ) In early stage of pulmonary fibrosis except in the control group, COX-2 expression was found in small bronchial epithelial cells in the other two groups, especially the model group. (2) Compared with the control group, the other two groups had alveolitis( P 〈 0.01 ). Alveolitis in the celecoxib group was hghter than in the BLM group ( P 〈 0. 05). (3) On 28th and 42th day, compared with the control group, the other two groups had polmonary fibrosis. Conclusion: COX-2 had a higher expression in small bronchial epithelial cells in lungs of bleomycin (BLM)-induced pulmonary fibrosis. Cyclooxygenase-2 inhibitor could reduce pulmonary inflammation in early stage, but couldn' t inhibit pulmonary fibrosis in the late stage.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3